# Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment

> **NCT06881810** · PHASE2 · RECRUITING · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 98 (estimated)

## Conditions studied

- Schizophrenia Spectrum Disorders (SSD)

## Interventions

- **DRUG:** Oxytocin nasal spray
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06881810
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-29
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881810, "Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06881810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*